LARIMAR THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $169.1M | $35.6M |
| FY2016 | $3.2M | $121.7M | $32.4M |
| FY2017 | $20.0M | $78.2M | $40.8M |
| FY2018 | $20.0M | $2.9M | $49.3M |
| FY2019 | $14.5M | $-694.0K | $1.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $169.1M | $35.6M |
| FY2016 | $3.2M | $121.7M | $32.4M |
| FY2017 | $20.0M | $78.2M | $40.8M |
| FY2018 | $20.0M | $2.9M | $49.3M |
| FY2019 | $14.5M | $-694.0K | $1.0M |